Skip to content
Search

Latest Stories

PDA launches vaccine portal for locum pharmacists

The Pharmacists’ Defence Association (PDA) has developed a web portal to assist locum pharmacists to access Covid-19 vaccination service similar to their fellow employed colleagues.

With the launch of the new portal, the association ensures self-employed locums that they can get the same access to Covid-19 vaccination priority as is do to their employed counterparts.


The locum vaccination portal will be available to all locums at zero cost, whether they are members of the PDA or not.

“The PDA’s work in this area is still ongoing and details of the NHS arrangements for pharmacist vaccination programmes for Wales, Scotland and Northern Ireland will be shared in the coming days,” the association said.

The portal will provide a mechanism to support identification of the most appropriate Clinical Commissioning Group (CCG) through which the locum could receive a vaccination.

Information provided by the locum will be shared with NHSE&I to share with the selected CCG.

Earlier, the PDA told the NHS that a mechanism was needed to enable locums to take charge of their own vaccination booking process after identifying which CCG would be most appropriate for them.

Following these discussions, the NHS has agreed that the PDA may operate a web portal that the PDA is creating specifically for this purpose.

“This will allow locums to select the CCG most proximate to their current geographical location. Once the list has been gathered from the whole of England, the details will be transferred directly to the respective CCG operational centres and they can arrange the vaccination appointments with locums directly,” the PDA said.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less